JAMA Network Home
Sign In
Editor's Pick Original Investigation

Federal and Industry Sponsorship in US Cancer Clinical Trials

JAMA Oncology 10.1001/jamaoncol.2026.3026

August 20, 2026 at 11:00 AM EDT

Read the full article

This comparative study of cancer clinical trial portfolios assesses differences between federal and industry sponsors in cancer clinical trial research.

JAMA+ Trials

Explore JAMA+ Trials for editor-curated JAMA Network clinical trials, commentary, multimedia, and more, led by Editor in Chief Alison Huang, MD, MAS.

Journalists may find Dr Huang's email newsletter, JAMA+ Trials "Theme of the Month," and the JAMA+ Trials search page helpful in reporting.

Corresponding Author: Joseph M. Unger, PhD, SWOG Statistics and Data Management Center, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, M3-C102, PO Box 19024, Seattle, WA 98109-1024 (junger@fredhutch.org).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2026.3026?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082026

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks